SCHEMBL6749219

SCHEMBL6749219

CCC(C(=O)O)C1C2CCCC1CN(C)C2

nearest known ligand 0.37

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CPN1 P15169 3/20 0.33
CPB2 Q96IY4 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6749204 0.78 CPN1 (0.38) CPN1CPB2
Hydrochloric Acid SCHEMBL6745852 0.77 CPN1 (0.37) CPN1CPB2
SCHEMBL6747366 0.76
SCHEMBL6749038 0.75 IDO1 (0.32) CPN1CPB2
Oxalic Acid SCHEMBL6747461 0.75 KDM4E (0.34)
SCHEMBL6745450 0.74 GRIN2B (0.45)
SCHEMBL6745770 0.72 IDO1 (0.33)
SCHEMBL13278433 0.70 CYP2C9 (0.44) CPN1CPB2
SCHEMBL7441458 0.69 CPN1 (0.47) CPN1CPB2
SCHEMBL6745649 0.69 CPB1 (0.31) CPB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040092737-A1 Benzopiperidine derivatives EISAI CO., LTD. 2004-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040092737-A1 Benzopiperidine derivatives HLA-DRB1, HRH1, HRH2 CPN1 4288/4885CPB2 2083/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.